MIR8052

Across TCGA pan-cancer cohorts, MIR8052 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR8052 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR8052 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8052 expression acts as an unfavorable survival marker.

KIRC, SKCM, and ESCA are the cancer types where MIR8052 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	54	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	54	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	27	view →
STAD	OS	Tertile	II,III,IV	0.279	0.726	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR8052–KIRC (DFS)

Open the KIRC breakdown →